OS Therapies Inc financial data

Symbol
OSTX on NYSE
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98% % 1471%
Debt-to-equity 1434% %
Return On Equity -6485% % -17136%
Return On Assets -252% % 56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35,214,352 shares 66%
Common Stock, Shares, Outstanding 33,269,981 shares 57%
Entity Public Float $0 USD
Common Stock, Value, Issued $33,270 USD 57%
Weighted Average Number of Shares Outstanding, Basic 15,897,460 shares 198%
Weighted Average Number of Shares Outstanding, Diluted 31,956,686 shares 101%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $8,434,456 USD 183%
General and Administrative Expense $11,249,774 USD 457%
Operating Income (Loss) $19,684,230 USD -293%
Nonoperating Income (Expense) $962,081 USD
Net Income (Loss) Attributable to Parent $18,284,245 USD -149%
Earnings Per Share, Basic -0.77 USD/shares -17%
Earnings Per Share, Diluted -0.77 USD/shares -17%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $2,321,691 USD 18%
Property, Plant and Equipment, Net $3,185 USD -52%
Assets $8,953,251 USD 353%
Accounts Payable, Current $3,374,287 USD 90%
Accrued Liabilities, Current $395,450 USD 33%
Liabilities, Current $4,145,351 USD 60%
Liabilities $4,245,351 USD 58%
Retained Earnings (Accumulated Deficit) $53,725,386 USD -52%
Stockholders' Equity Attributable to Parent $3,637,195 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,186,578 USD 84%
Liabilities and Equity $8,953,251 USD 353%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,441,884 USD -436%
Net Cash Provided by (Used in) Financing Activities $1,053,000 USD 50%
Net Cash Provided by (Used in) Investing Activities $173,636 USD
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 33,269,981 shares 57%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,876,626 USD 1%
Deferred Tax Assets, Valuation Allowance $8,501,235 USD 31%
Deferred Tax Assets, Gross $8,501,235 USD 31%
Depreciation $695 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $6,559,791 USD 37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Operating Lease, Payments $788 USD
Additional Paid in Capital $35,144,967 USD 540%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $941,283 USD
Interest Expense $828,760 USD 3.7%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%